TETERBORO, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the UBS Global
Life Sciences Conference on Tuesday, September 28, 2004, at The Grand Hyatt
Hotel in New York City. The Quest Diagnostics presentation is scheduled to
begin at 3:00 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://event.streamx.us/event/default.asp?Event=UBS20040927 and to the public
on http://www.questdiagnostics.com. In addition, the archived webcast will be
available starting approximately three hours after the live presentation and
will be available for 30 days.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
healthcare professionals to make decisions that improve health. The company
offers the broadest access to diagnostic testing services through its national
network of laboratories and patient service centers, and provides interpretive
consultation through its extensive medical and scientific staff. Quest
Diagnostics is the leading provider of esoteric testing, including gene-based
medical testing, and provides advanced information technology solutions to
improve patient care. Additional company information is available at:
http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2003 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
-0- 09/27/2004
/CONTACT: Investors: Laure Park, +1-201-393-5030, or Media: Gary Samuels,
+1-201-393-5700, both of Quest Diagnostics Incorporated/
/Web site: http://www.questdiagnostics.com
http://event.streamx.us/event/default.asp?Event=UBS20040927 /
(DGX)